Russia’s Chumakov Center has started phase three trials of CoviVac, Russia’s third vaccine against COVID-19, the Interfax news agency cited a government minister as saying on Thursday, APA reports citing Reuters.

The most well known Russian coronavirus vaccine is Sputnik V. Moscow has also given emergency approval to two others, EpiVacCorona and CoviVac.